背景与目的比马前列素眼用溶液(0.03%)用于治疗高眼压症。然而,这种处方的副作用之一是它导致睫毛过度生长,导致多毛症.因此,比马前列素眼用溶液被重新命名为用于美容目的.这项研究旨在评估女大学生对使用Careprost(Bimatoprost,拉蒂斯,Allergan,Inc.,Irvine,CA)用于化妆品目的。方法在Bisha大学的女学生中进行了描述性横断面研究,包括医学院和非医学院的,从2022年11月到2023年2月。所有完成研究问卷的参与者都被考虑进行分析,但是那些没有答案的人被排除在研究之外。参与者总数为305,在分发的376项调查中,回应率为81.2%。结果共有305名学生完成调查,医学院约有132人(54.5%),非医学院约有173人(65.3%)。来自医学院的约32(24.2%)参与者和来自非医学院的51(29.4%)参与者了解比马前列素滴剂可用于延长睫毛。超过一半的参与者不知道Careprost的副作用(0.03%),包括65名(49.2%)医学生和108名(62.7%)非医学生。总的来说,42(13.77%)的参与者认为Careprost(0.03%)可以在没有处方的情况下给药。在参与者中,75(24.59%)报告他们以前使用过Careprost(0.03%)滴眼液。此外,超过四分之一(83,27.2%)的参与者认为Careprost(0.03%)可用于睫毛伸长.结论这项研究表明,女大学生对Careprost(0.03%)眼药水用于睫毛的化妆品使用的认识和实践水平较差。注意到关于Careprost滴剂的副作用的意识水平更好,这可能导致女学生的利用率较低。
Background and objective Bimatoprost ophthalmic solution (0.03%) is used for the treatment of ocular hypertension. However, one of the side effects of this prescription is that it causes overgrowth of
eyelashes, causing hypertrichosis. Therefore, the Bimatoprost ophthalmic solution was rebranded to be used for cosmetic purposes. This study aims to assess the awareness and practices of female university students regarding the use of Careprost (Bimatoprost, Latisse, Allergan, Inc., Irvine, CA) for cosmetic purposes. Methodology A descriptive cross-sectional study was conducted among female students at Bisha University, including those from medical and non-medical colleges, spanning from November 2022 to February 2023. All participants who completed the study questionnaire were considered for analysis, but those who had missing answers were excluded from the study. The total number of participants was 305, representing an 81.2% response rate out of the 376 surveys distributed. Results A total of 305 students completed the survey, with approximately 132 (54.5%) from the medical college and 173 (65.3%) from the non-medical college. Approximately 32 (24.2%) of participants from the medical college and 51 (29.4%) from the non-medical college understood that Bimatoprost drops can be used for the elongation of
eyelashes. More than half of the participants were not aware of the side effects of Careprost (0.03%), including 65 (49.2%) medical students and 108 (62.7%) non-medical students. In total, 42 (13.77%) of the participants believed that Careprost (0.03%) could be administered without a prescription. Among the participants, 75 (24.59%) reported that they had previously used Careprost (0.03%) eye drops. Additionally, more than one-fourth of the participants (83, 27.2%) thought that Careprost (0.03%) could be used for eyelash elongation. Conclusions This study revealed that female university students had a poor level of awareness and practices about the cosmetic uses of Careprost (0.03%) eye drops for
eyelashes. A better awareness level was noted regarding the side effects of Careprost drops, which may have contributed to a low utilization rate among female students.